NASDAQ:NBEV - NewAge Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $6.00
  • Forecasted Upside: 383.87 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$1.24
▼ -0.03 (-2.36%)

This chart shows the closing price for NBEV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New NewAge Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NBEV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NBEV

Analyst Price Target is $6.00
▲ +383.87% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for NewAge in the last 3 months. The average price target is $6.00, with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 383.87% upside from the last price of $1.24.

This chart shows the closing price for NBEV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in NewAge. This rating has held steady since June 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/10/2021Alliance Global PartnersReiterated RatingBuyHigh
8/10/2021Roth CapitalLower Price TargetBuy$6.50 ➝ $6.00High
8/4/2021Roth CapitalReiterated RatingBuyLow
7/22/2020Northland SecuritiesInitiated CoverageHoldHigh
7/21/2020Alliance Global PartnersBoost Price Target$3.50 ➝ $5.00High
4/17/2020Northland SecuritiesReiterated RatingHoldHigh
3/11/2020Compass PointLower Price Target$9.00 ➝ $4.00Medium
11/15/2019Alliance Global PartnersLower Price TargetBuy$6.00 ➝ $3.50Medium
11/14/2019Northland SecuritiesInitiated CoverageHold$3.50Low
8/8/2019Northland SecuritiesReiterated RatingHold$5.00High
7/22/2019Northland SecuritiesDowngradeOutperform ➝ Market Perform$8.00 ➝ $5.00High
6/10/2019Compass PointInitiated CoverageBuy$9.00Low
6/4/2019Northland SecuritiesReiterated RatingBuy$8.00Low
5/10/2019Maxim GroupReiterated RatingHoldMedium
4/1/2019Northland SecuritiesReiterated RatingBuy$8.00Low
3/26/2019Alliance Global PartnersInitiated CoverageBuy$8.00High
1/7/2019Northland SecuritiesBoost Price TargetOutperform ➝ Sell$6.00 ➝ $8.00Low
12/4/2018Roth CapitalBoost Price TargetBuy$7.00 ➝ $10.00Low
9/21/2018Maxim GroupDowngradeBuy ➝ HoldHigh
9/4/2018Northland SecuritiesInitiated CoverageOutperform ➝ Outperform$3.00High
8/16/2018Maxim GroupLower Price TargetBuy ➝ Buy$5.00 ➝ $3.00High
4/18/2018Maxim GroupLower Price TargetBuy ➝ Buy$6.00 ➝ $5.00High
12/4/2017AegisReiterated RatingBuyLow
11/17/2017Maxim GroupLower Price TargetBuy ➝ Buy$7.50 ➝ $6.00N/A
7/27/2017Roth CapitalInitiated CoverageBuy ➝ Buy$7.50High
5/22/2017Maxim GroupBoost Price TargetBuy$6.00 ➝ $7.50High
5/4/2017Maxim GroupInitiated CoverageBuy ➝ Buy$6.00High
5/1/2017AegisInitiated CoverageBuy$6.25High
(Data available from 11/27/2016 forward)

News Sentiment Rating

0.10 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 9 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/30/2021
  • 7 very positive mentions
  • 15 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
8/29/2021
  • 6 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
9/28/2021
  • 3 very positive mentions
  • 11 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
10/28/2021
  • 3 very positive mentions
  • 23 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
11/27/2021

Current Sentiment

  • 3 very positive mentions
  • 23 positive mentions
  • 5 negative mentions
  • 2 very negative mentions

Recent Stories by Sentiment

NewAge logo
NewAge Inc is engaged in the business of developing, marketing, selling, and distributing a portfolio of healthy products. It offers a portfolio of healthy products with its brands across platforms, such as health & wellness, inner & outer beauty, and nutrition & weight management. Its partner companies include ARIIX, Noni, LIMU, and ZENNOA. The company was founded by Neil Fallon on April 26, 2010 and is headquartered in Denver, CO.
Read More

Today's Range

Now: $1.24
Low: $1.21
High: $1.26

50 Day Range

MA: $1.43
Low: $1.18
High: $1.67

52 Week Range

Now: $1.24
Low: $1.16
High: $4.55

Volume

1,195,556 shs

Average Volume

1,728,073 shs

Market Capitalization

$169.62 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Frequently Asked Questions

What sell-side analysts currently cover shares of NewAge?

The following Wall Street sell-side analysts have issued reports on NewAge in the last year: Alliance Global Partners, Roth Capital, and Zacks Investment Research.
View the latest analyst ratings for NBEV.

What is the current price target for NewAge?

1 Wall Street analysts have set twelve-month price targets for NewAge in the last year. Their average twelve-month price target is $6.00, suggesting a possible upside of 383.9%. Roth Capital has the highest price target set, predicting NBEV will reach $6.00 in the next twelve months. Roth Capital has the lowest price target set, forecasting a price of $6.00 for NewAge in the next year.
View the latest price targets for NBEV.

What is the current consensus analyst rating for NewAge?

NewAge currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NBEV will outperform the market and that investors should add to their positions of NewAge.
View the latest ratings for NBEV.

How do I contact NewAge's investor relations team?

NewAge's physical mailing address is 2420 17TH STREET SUITE 220, DENVER CO, 80202. The company's listed phone number is (303) 566-3030 and its investor relations email address is [email protected] The official website for NewAge is newagebev.us.